Wellington Management Group’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14M Buy
422,129
+397,667
+1,626% +$13.2M ﹤0.01% 1101
2025
Q1
$717K Sell
24,462
-1,027
-4% -$30.1K ﹤0.01% 1769
2024
Q4
$838K Sell
25,489
-3,959
-13% -$130K ﹤0.01% 1731
2024
Q3
$1.31M Sell
29,448
-6,971
-19% -$310K ﹤0.01% 1650
2024
Q2
$1.57M Sell
36,419
-3,425
-9% -$148K ﹤0.01% 1565
2024
Q1
$1.17M Sell
39,844
-5,623
-12% -$164K ﹤0.01% 1646
2023
Q4
$1.01M Sell
45,467
-5,153,596
-99% -$115M ﹤0.01% 1626
2023
Q3
$129M Sell
5,199,063
-666,565
-11% -$16.5M 0.03% 456
2023
Q2
$166M Buy
5,865,628
+142,497
+2% +$4.04M 0.03% 429
2023
Q1
$131M Buy
5,723,131
+260,474
+5% +$5.98M 0.03% 476
2022
Q4
$153M Buy
5,462,657
+314,244
+6% +$8.82M 0.03% 439
2022
Q3
$146M Hold
5,148,413
0.03% 433
2022
Q2
$114M Sell
5,148,413
-153
-0% -$3.39K 0.02% 507
2022
Q1
$150M Hold
5,148,566
0.03% 485
2021
Q4
$169M Sell
5,148,566
-33,787
-0.7% -$1.11M 0.03% 490
2021
Q3
$239M Sell
5,182,353
-1,587,362
-23% -$73.3M 0.04% 396
2021
Q2
$373M Sell
6,769,715
-83,881
-1% -$4.62M 0.06% 292
2021
Q1
$354M Sell
6,853,596
-1,023,774
-13% -$52.9M 0.06% 297
2020
Q4
$341M Sell
7,877,370
-32,838
-0.4% -$1.42M 0.06% 291
2020
Q3
$277M Buy
7,910,208
+43,331
+0.6% +$1.52M 0.06% 284
2020
Q2
$421M Sell
7,866,877
-13,744
-0.2% -$735K 0.09% 196
2020
Q1
$280M Sell
7,880,621
-81,102
-1% -$2.88M 0.07% 236
2019
Q4
$380M Buy
7,961,723
+1,248,120
+19% +$59.6M 0.08% 247
2019
Q3
$218M Sell
6,713,603
-92,637
-1% -$3M 0.05% 352
2019
Q2
$339M Sell
6,806,240
-1,340,703
-16% -$66.9M 0.08% 259
2019
Q1
$549M Buy
8,146,943
+3,827
+0% +$258K 0.12% 179
2018
Q4
$375M Buy
8,143,116
+275,737
+4% +$12.7M 0.09% 223
2018
Q3
$607M Buy
7,867,379
+220,679
+3% +$17M 0.13% 181
2018
Q2
$644M Sell
7,646,700
-125,574
-2% -$10.6M 0.14% 169
2018
Q1
$636M Buy
7,772,274
+946,674
+14% +$77.4M 0.14% 166
2017
Q4
$390M Buy
6,825,600
+55,810
+0.8% +$3.19M 0.09% 243
2017
Q3
$452M Buy
6,769,790
+21,303
+0.3% +$1.42M 0.1% 211
2017
Q2
$347M Buy
6,748,487
+854,891
+15% +$44M 0.08% 244
2017
Q1
$344M Buy
5,893,596
+11,528
+0.2% +$673K 0.08% 231
2016
Q4
$245M Buy
5,882,068
+83,737
+1% +$3.49M 0.06% 277
2016
Q3
$306M Buy
5,798,331
+489,281
+9% +$25.8M 0.08% 247
2016
Q2
$222M Buy
5,309,050
+9,972
+0.2% +$418K 0.06% 289
2016
Q1
$215M Buy
5,299,078
+31,611
+0.6% +$1.28M 0.06% 299
2015
Q4
$342M Buy
5,267,467
+290,353
+6% +$18.8M 0.09% 219
2015
Q3
$351M Buy
4,977,114
+652,198
+15% +$46M 0.1% 214
2015
Q2
$481M Buy
4,324,916
+1,079,278
+33% +$120M 0.12% 176
2015
Q1
$306M Buy
3,245,638
+1,231,158
+61% +$116M 0.08% 251
2014
Q4
$226M Buy
2,014,480
+351,290
+21% +$39.4M 0.06% 315
2014
Q3
$102M Buy
1,663,190
+575,758
+53% +$35.3M 0.03% 496
2014
Q2
$49.8M Sell
1,087,432
-21,910
-2% -$1M 0.01% 746
2014
Q1
$43.4M Sell
1,109,342
-247,551
-18% -$9.69M 0.01% 787
2013
Q4
$32.5M Buy
1,356,893
+260,605
+24% +$6.24M 0.01% 865
2013
Q3
$30.7M Buy
+1,096,288
New +$30.7M 0.01% 855